Back to mobile site

Mast Therapeutics (MSTX) Reports In-Line Q2 EPS

August 12, 2015 4:45 PM EDT

Mast Therapeutics (NYSE: MSTX) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06).

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings